• Partner With Us
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Abundance & Growth
      • Effective Giving & Careers
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Global Health R&D
      • Global Public Health Policy
      • Scientific Research
    • Global Catastrophic Risks
      • Biosecurity & Pandemic Preparedness
      • Forecasting
      • Global Catastrophic Risks Capacity Building
      • Potential Risks from Advanced AI
    • Other Areas
      • History of Philanthropy
  • Grants
  • Research & Updates
    • Blog Posts
    • In the News
    • Research Reports
    • Notable Lessons
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Careers
    • Team
    • Operating Values
    • Stay Updated
    • Contact Us
  • Partner With Us
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Abundance & Growth
      • Effective Giving & Careers
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Global Health R&D
      • Global Public Health Policy
      • Scientific Research
    • Global Catastrophic Risks
      • Biosecurity & Pandemic Preparedness
      • Forecasting
      • Global Catastrophic Risks Capacity Building
      • Potential Risks from Advanced AI
    • Other Areas
      • History of Philanthropy
  • Grants
  • Research & Updates
    • Blog Posts
    • In the News
    • Research Reports
    • Notable Lessons
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Careers
    • Team
    • Operating Values
    • Stay Updated
    • Contact Us

Beth Israel Deaconess Medical Center — Sepsis Therapy Clinical Trial (Michael Donnino)

Visit Grantee Site
  • Portfolio Area: Human Health and Wellbeing
  • Focus Area: Scientific Research
  • Organization Name: Beth Israel Deaconess Medical Center
  • Amount: $2,939,400

  • Award Date: January 2018

Table of Contents

    Dr. Donnino will lead research on a sepsis treatment with ascorbic acid (Vitamin C) combined with hydrocortisone and thiamine. (Photo courtesy of Joel Haskell)

    Grant investigators: Chris Somerville and Heather Youngs

    This page was reviewed but not written by the grant investigators. Drs. Donnino and Marik reviewed this page prior to publication.

    The Open Philanthropy Project recommended a grant of $2,939,400 to the Beth Israel Deaconess Medical Center to support a multicenter clinical trial of a new therapy for severe sepsis, led by Dr. Michael Donnino of Harvard. Sepsis, most commonly the result of bacterial infection of the lungs or other organs, is a significant cause of mortality both in the United States and worldwide, resulting in an estimated 5.3 million deaths annually.1

    The trial will test the utility of a therapy first described by Dr. Paul E. Marik and colleagues, which involved administering a combination of drugs that included hydrocortisone and thiamine with ascorbic acid to treat patients with severe sepsis.2 Dr. Marik’s treatment suggested significant improvements in outcomes, however the study was small and not randomized, and so the results are merely suggestive of impact. The new trial, led by Dr. Donnino with Dr. Marik as a co-investigator, is intended to more rigorously test the treatment through a larger, randomized study. If shown to be effective, we believe the treatment could be adopted relatively quickly around the world, as the necessary components are both inexpensive and readily available. We therefore view this funding as an opportunity to substantially accelerate the adoption of a potentially life-saving therapy.

    We originally became aware of this opportunity through this blog post.3 We initially did not see an opportunity to accelerate progress because plans for other trials were underway. We chose to fund this trial despite the fact that other trials are planned because we believe that this trial is likely to be completed earlier than others, leading to swifter adoption if the treatment succeeds.

    This grant falls within our interest in funding scientific research.

    Sources

    DOCUMENT SOURCE
    Assessment of Global Incidence and Mortality of Hospital-treated Sepsis Source (archive)
    Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study, 2017 Source (archive)
    Otium Blog, Sepsis Cure Needs An RCT, April 2017 [archive only] Source
    Expand Footnotes Collapse Footnotes

    1.“…a tentative extrapolation from high-income country data suggests global estimates of 31.5 million sepsis and 19.4 million severe sepsis cases, with potentially 5.3 million deaths annually.” Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations, 2016

    2.“In this retrospective before-after clinical study, we compared the outcome and clinical course of consecutive septic patients treated with intravenous vitamin C, hydrocortisone, and thiamine during a 7-month period (treatment group) with a control group treated in our ICU during the preceding 7 months. The primary outcome was hospital survival … Our results suggest that the early use of intravenous vitamin C, together with corticosteroids and thiamine, are effective in preventing progressive organ dysfunction, including acute kidney injury, and in reducing the mortality of patients with severe sepsis and septic shock. Additional studies are required to confirm these preliminary findings.” Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study, 2017

    3.Archived copy of link: Otium Blog, Sepsis Cure Needs An RCT, April 2017 [archive only]

    Related Items

    • Human Health and Wellbeing

      Beth Israel Deaconess Medical Center — Long COVID Therapy Trial

      Open Philanthropy recommended a grant of $1,500,000 over three years to Beth Israel Deaconess Medical Center to support a randomized controlled trial, led by Professor Michael Donnino, that will...

      Read more
    • Human Health and Wellbeing

      Hemex Health — Diagnostic Products

      Open Philanthropy recommended an investment of $2,349,999 in Hemex Health to produce and distribute a rapid assay for the diagnosis of sickle cell disease, as well as diagnostic...

      Read more
    • Human Health and Wellbeing

      University of Southern California — Clinical Trial for Preterm Birth Supplements

      Open Philanthropy recommended a gift of $1,070,495 over four years to the University of Southern California to support a clinical trial of combination supplements that have been...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • We’re Hiring!
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    info@openphilanthropy.org
    Media Inquiries
    media@openphilanthropy.org
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2025 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT